OTCMKTS:VYCO Vycor Medical (VYCO) Stock Price, News & Analysis → Discover How to Turn $10,000 into $1 Million (From Paradigm Press) (Ad) Free VYCO Stock Alerts $0.09 0.00 (0.00%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$0.09▼$0.0950-Day Range$0.08▼$0.1352-Week Range$0.04▼$0.13VolumeN/AAverage Volume2,081 shsMarket Capitalization$2.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get Vycor Medical alerts: Email Address Ad Paradigm PressDiscover How to Turn $10,000 into $1 MillionToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.That will slam shut June 25. About Vycor Medical Stock (OTCMKTS:VYCO)Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.Read More VYCO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VYCO Stock News HeadlinesJune 14 at 6:10 AM | americanbankingnews.comVycor Medical, Inc. (OTCMKTS:VYCO) Sees Significant Increase in Short InterestJanuary 7, 2023 | finance.yahoo.comVycor Medical, Inc. (VYCO)November 1, 2022 | health.usnews.comMedical Review BoardSeptember 8, 2022 | reuters.comVycor Medical IncDecember 17, 2021 | nasdaq.comVycor Medical Inc (VYCO)See More Headlines Receive VYCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vycor Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/17/2020Today6/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:VYCO Previous SymbolOTCMKTS:VYCO CUSIP92921M203 CIK1424768 Webwww.vycormedical.com Phone(561) 558-2000Fax631-794-2444Employees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.46 million Price / Sales2.01 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares32,630,000Free Float30,335,000Market Cap$2.94 million OptionableNot Optionable Beta0.48 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Peter C. Zachariou (Age 62)CEO & Director Mr. David Marc Cantor (Age 58)President & Director Mr. Adrian Christopher Liddell (Age 65)Chairman & CFO Key CompetitorsSeaStar MedicalNASDAQ:ICUSTRATA Skin SciencesNASDAQ:SSKNPAVmedNASDAQ:PAVMBiotricityNASDAQ:BTCYNeuroMetrixNASDAQ:NUROView All Competitors VYCO Stock Analysis - Frequently Asked Questions How have VYCO shares performed in 2024? Vycor Medical's stock was trading at $0.0772 at the start of the year. Since then, VYCO shares have increased by 16.6% and is now trading at $0.09. View the best growth stocks for 2024 here. Are investors shorting Vycor Medical? Vycor Medical saw a increase in short interest in May. As of May 31st, there was short interest totaling 1,500 shares, an increase of 114.3% from the May 15th total of 700 shares. Based on an average daily trading volume, of 6,900 shares, the days-to-cover ratio is currently 0.2 days. View Vycor Medical's Short Interest. How were Vycor Medical's earnings last quarter? Vycor Medical, Inc. (OTCMKTS:VYCO) released its earnings results on Monday, August, 17th. The medical device company reported ($0.01) earnings per share (EPS) for the quarter. The medical device company had revenue of $0.24 million for the quarter. What other stocks do shareholders of Vycor Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vycor Medical investors own include Fly Leasing (FLY), Idera Pharmaceuticals (IDRA), ACADIA Pharmaceuticals (ACAD), Bellicum Pharmaceuticals (BLCM), Drone Aviation (DRNE), Intercept Pharmaceuticals (ICPT), Paratek Pharmaceuticals (PRTK) and Shopify (SHOP). How do I buy shares of Vycor Medical? Shares of VYCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VYCO) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does ...Porter & Company | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vycor Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vycor Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.